The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy (Q84357726)
Jump to navigation
Jump to search
scientific article published on 01 June 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy |
scientific article published on 01 June 2010 |
Statements
The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy (English)
Elliott D Crouser
Gerard Lozanski
Charity C Fox
David W Hauswirth
Rekha Raveendran